Severity and Impact of Gastrointestinal Symptoms in Patients with SSc-ILD Treated with Nintedanib: Data from SENSCIS-ON - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Arthritis and Rheumatology (hoboken, N.j.) Année : 2021

Severity and Impact of Gastrointestinal Symptoms in Patients with SSc-ILD Treated with Nintedanib: Data from SENSCIS-ON

Fichier non déposé

Dates et versions

hal-03607748 , version 1 (14-03-2022)

Identifiants

  • HAL Id : hal-03607748 , version 1

Citer

Dinesh Khanna, Elizabeth Volkmann, Kristin B. Highland, Yannick Allanore, Stéphane Jouneau, et al.. Severity and Impact of Gastrointestinal Symptoms in Patients with SSc-ILD Treated with Nintedanib: Data from SENSCIS-ON. Arthritis and Rheumatology (hoboken, N.j.), 2021, 73 (59), pp.804-807. ⟨hal-03607748⟩
16 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More